Skip to main content
Top
Published in: BMC Public Health 1/2019

Open Access 01-12-2019 | Research article

The relative impact of smoking, alcohol use and drug use on general sickness absence among Norwegian employees

Authors: Ingeborg Lund, Inger Synnøve Moan, Hilde Marie Erøy Edvardsen

Published in: BMC Public Health | Issue 1/2019

Login to get access

Abstract

Background

It is well documented that tobacco, alcohol and drug use can be detrimental to health. However, little is known about the relative impact of these factors on sickness absence, and whether the association between use of these substances and sickness absence is different for women and men. The aim of this study was to examine the association between tobacco-, alcohol- and drug use, as well as polydrug use, and sickness absence among Norwegian employees.

Methods

During 2011–2014, 1911 employees in Norway completed a questionnaire about their tobacco, alcohol and drug use habits, their total number of sickness absences during the last 12 months, and the length (no. of days) of their last sick leave. Samples of oral fluid were analysed for illegal and medicinal drugs.

Results

Daily smoking and current use of medical drugs were significantly associated with sickness absence. Employees who were daily smokers also had an increased likelihood of having long and frequent sickness absence. Use of snus (Swedish moist snuff), binge drinking, current use of illegal drugs and polydrug use were not significantly associated with sickness absence. Women and young participants were more likely to report having had sickness absence the past 12 months. However, the associations between daily smoking and medical drug use and sickness absence, respectively, were only statistically significant for men.

Conclusion

According to this study, daily smoking and use of medical drugs are the substance use habits most closely associated with sickness absence. Implications for future research are discussed.
Literature
2.
go back to reference Barmby TA, Ercolani MG, Treble JG. Sickness absence: an international comparison. EJ. 2002;112:F315–F31. Barmby TA, Ercolani MG, Treble JG. Sickness absence: an international comparison. EJ. 2002;112:F315–F31.
3.
go back to reference Degenhardt L, Whiteford HA, Ferrari AJ, et al. Global burden of disease attributable to illicit drug use and dependence: findings from the global burden of disease study 2010. Lancet. 2013;382:1564–74.CrossRefPubMed Degenhardt L, Whiteford HA, Ferrari AJ, et al. Global burden of disease attributable to illicit drug use and dependence: findings from the global burden of disease study 2010. Lancet. 2013;382:1564–74.CrossRefPubMed
4.
go back to reference Forouzanfar MH, Afshin A, Alexander LT, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388:1659–724.CrossRef Forouzanfar MH, Afshin A, Alexander LT, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388:1659–724.CrossRef
5.
go back to reference Vedøy TF. Utbredelse av sigarettrøyking i Norge [The prevalence of cigarette smoking in Norway]. In: Lund KE, (ed.). Tobacco in Norway. Oslo: Report, Norwegian Institute of Public Health; 2018. Vedøy TF. Utbredelse av sigarettrøyking i Norge [The prevalence of cigarette smoking in Norway]. In: Lund KE, (ed.). Tobacco in Norway. Oslo: Report, Norwegian Institute of Public Health; 2018.
6.
go back to reference Vedøy TF, Lund KE. Utbredelse av snus i Norge [the prevalence of snus use in Norway] In: Lund KE, (ed.). Tobacco in Norway. Oslo: Report, Norwegian Institute of Public Health; 2018. Vedøy TF, Lund KE. Utbredelse av snus i Norge [the prevalence of snus use in Norway] In: Lund KE, (ed.). Tobacco in Norway. Oslo: Report, Norwegian Institute of Public Health; 2018.
7.
go back to reference Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.CrossRefPubMed Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.CrossRefPubMed
8.
go back to reference Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370:765–73.CrossRefPubMed Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370:765–73.CrossRefPubMed
9.
go back to reference U.S. Department of Health and Human Services. The health consequences of smoking: a report of the Surgeon General. Washington D.C.: Report, U.S. Department of Health and Human Service; 2004. U.S. Department of Health and Human Services. The health consequences of smoking: a report of the Surgeon General. Washington D.C.: Report, U.S. Department of Health and Human Service; 2004.
10.
go back to reference Arefalk G, Galanti R, Lundberg M, et al. Smokeless tobacco (snus) and risk of heart failure of ischemic and non-ischemic origin: a pooled analysis of eight prospective cohort studies. In: PhD thesis smokeless tobacco (snus) and cardiovascular disease: associations with heart failure and prognosis after myocardial infarction. Sweden: Uppsala University; 2018. Arefalk G, Galanti R, Lundberg M, et al. Smokeless tobacco (snus) and risk of heart failure of ischemic and non-ischemic origin: a pooled analysis of eight prospective cohort studies. In: PhD thesis smokeless tobacco (snus) and cardiovascular disease: associations with heart failure and prognosis after myocardial infarction. Sweden: Uppsala University; 2018.
11.
go back to reference Araghi M, Rosaria Galanti M, Lundberg M, et al. Use of moist oral snuff (snus) and pancreatic cancer: pooled analysis of nine prospective observational studies. Int J Cancer. 2017;141:687–93.CrossRefPubMed Araghi M, Rosaria Galanti M, Lundberg M, et al. Use of moist oral snuff (snus) and pancreatic cancer: pooled analysis of nine prospective observational studies. Int J Cancer. 2017;141:687–93.CrossRefPubMed
12.
go back to reference Almirall J, Bolibar I, Balanzo X, Gonzalez C. Risk factors for community-acquired pneumonia in adults: a population-based case-control study. Eur Respir J. 1999;13:349–55.CrossRefPubMed Almirall J, Bolibar I, Balanzo X, Gonzalez C. Risk factors for community-acquired pneumonia in adults: a population-based case-control study. Eur Respir J. 1999;13:349–55.CrossRefPubMed
13.
go back to reference Alavinia SM, van den Berg TIJ, van Duivenbooden C, Elders LAM, Burdorf A. Impact of work-related factors, lifestyle, and work ability on sickness absence among Dutch construction workers. Scand J Work Environ Health. 2009;35:325–33.CrossRefPubMed Alavinia SM, van den Berg TIJ, van Duivenbooden C, Elders LAM, Burdorf A. Impact of work-related factors, lifestyle, and work ability on sickness absence among Dutch construction workers. Scand J Work Environ Health. 2009;35:325–33.CrossRefPubMed
14.
go back to reference Laaksonen M, Piha K, Martikainen P, Rahkonen O, Lahelma E. Health-related behaviours and sickness absence from work. Occup Environ Med. 2009;66:840–7.CrossRefPubMed Laaksonen M, Piha K, Martikainen P, Rahkonen O, Lahelma E. Health-related behaviours and sickness absence from work. Occup Environ Med. 2009;66:840–7.CrossRefPubMed
15.
go back to reference Babor TF, Babor T, Caetano R, Casswell S, Edwards G, Giesbrecht N. Alcohol: no ordinary commodity: research and public policy. New York: Oxford University Press; 2010.CrossRef Babor TF, Babor T, Caetano R, Casswell S, Edwards G, Giesbrecht N. Alcohol: no ordinary commodity: research and public policy. New York: Oxford University Press; 2010.CrossRef
16.
17.
go back to reference Schou L, Moan IS. Alcohol use–sickness absence association and the moderating role of gender and socioeconomic status: a literature review. Drug Alcohol rev. 2016;35:158–69.CrossRefPubMed Schou L, Moan IS. Alcohol use–sickness absence association and the moderating role of gender and socioeconomic status: a literature review. Drug Alcohol rev. 2016;35:158–69.CrossRefPubMed
18.
go back to reference Buvik K, Moan IS, Halkjelsvik T. Alcohol-related absence and presenteeism: beyond productivity loss. Int J Drug Policy. 2018;58:71–7.CrossRefPubMed Buvik K, Moan IS, Halkjelsvik T. Alcohol-related absence and presenteeism: beyond productivity loss. Int J Drug Policy. 2018;58:71–7.CrossRefPubMed
19.
go back to reference Edvardsen HME, Moan IS, Christophersen AS, Gjerde H. Use of alcohol and drugs by employees in selected business areas in Norway: a study using oral fluid testing and questionnaires. J Occup Med Toxicol. 2015;10:46.CrossRefPubMedPubMedCentral Edvardsen HME, Moan IS, Christophersen AS, Gjerde H. Use of alcohol and drugs by employees in selected business areas in Norway: a study using oral fluid testing and questionnaires. J Occup Med Toxicol. 2015;10:46.CrossRefPubMedPubMedCentral
20.
go back to reference Østby KA, Czajkowski N, Knudsen GP, et al. Does low alcohol use increase the risk of sickness absence? A discordant twin study. BMC Public Health. 2016;16:825.CrossRefPubMedPubMedCentral Østby KA, Czajkowski N, Knudsen GP, et al. Does low alcohol use increase the risk of sickness absence? A discordant twin study. BMC Public Health. 2016;16:825.CrossRefPubMedPubMedCentral
21.
go back to reference Norström T, Moan IS. Per capita alcohol consumption and sickness absence in Norway. Eur J Public Health. 2009;19:383–8.CrossRefPubMed Norström T, Moan IS. Per capita alcohol consumption and sickness absence in Norway. Eur J Public Health. 2009;19:383–8.CrossRefPubMed
22.
go back to reference Grimsmo A, Rossow I. Alkohol og sykefravær (Alcohol and sickness absence) report, vol. 3. Oslo: the National Institute for Alcohol and Drug Research; 1997. p. 97. Grimsmo A, Rossow I. Alkohol og sykefravær (Alcohol and sickness absence) report, vol. 3. Oslo: the National Institute for Alcohol and Drug Research; 1997. p. 97.
23.
go back to reference French MT, Zarkin GA, Dunlap LJ. Illicit drug use, absenteeism, and earnings at six US worksites. Contemp Econ Policy. 1998;16:334–46.CrossRef French MT, Zarkin GA, Dunlap LJ. Illicit drug use, absenteeism, and earnings at six US worksites. Contemp Econ Policy. 1998;16:334–46.CrossRef
24.
go back to reference Gates P, Roxburgh A, Copeland J. Cannabis and other drug use in the Australian workforce: findings from the 2007 NDSHS data, National Cannabis Prevention and Information Centre Bulletin, vol. 8; 2009. p. 1–9. Gates P, Roxburgh A, Copeland J. Cannabis and other drug use in the Australian workforce: findings from the 2007 NDSHS data, National Cannabis Prevention and Information Centre Bulletin, vol. 8; 2009. p. 1–9.
25.
go back to reference Jonsson P, Linde M, Hensing G, Hedenrud T. Sociodemographic differences in medication use, health-care contacts and sickness absence among individuals with medication-overuse headache. J Headache Pain. 2012;13:281–90.CrossRefPubMedPubMedCentral Jonsson P, Linde M, Hensing G, Hedenrud T. Sociodemographic differences in medication use, health-care contacts and sickness absence among individuals with medication-overuse headache. J Headache Pain. 2012;13:281–90.CrossRefPubMedPubMedCentral
26.
go back to reference Mccabe SE, Cranford JA, Morales M, Young A. Simultaneous and concurrent polydrug use of alcohol and prescription drugs: prevalence, correlates, and consequences. J Stud Alcohol. 2006;67:529–37.CrossRefPubMedPubMedCentral Mccabe SE, Cranford JA, Morales M, Young A. Simultaneous and concurrent polydrug use of alcohol and prescription drugs: prevalence, correlates, and consequences. J Stud Alcohol. 2006;67:529–37.CrossRefPubMedPubMedCentral
27.
go back to reference Virtanen M, Ervasti J, Head J. Lifestyle factors and risk of sickness absence from work: a multicohort study. Lancet Public Health. 2018;3(11):e545–54.CrossRefPubMedPubMedCentral Virtanen M, Ervasti J, Head J. Lifestyle factors and risk of sickness absence from work: a multicohort study. Lancet Public Health. 2018;3(11):e545–54.CrossRefPubMedPubMedCentral
28.
go back to reference Østby K, Mykletun A, Nilsen W. Explaining the gender gap in sickness absence. Occup Med. 2018;68:320–6.CrossRef Østby K, Mykletun A, Nilsen W. Explaining the gender gap in sickness absence. Occup Med. 2018;68:320–6.CrossRef
29.
go back to reference Markussen S, Røed K, Røgeber OJ, Gaure S. The anatomy of absenteeism. J Health Econ. 2011;30(2):277–92.CrossRefPubMed Markussen S, Røed K, Røgeber OJ, Gaure S. The anatomy of absenteeism. J Health Econ. 2011;30(2):277–92.CrossRefPubMed
30.
go back to reference Lund I, Kvaavik E, Nygård M, Hansen BT. Associations between snus use, body mass index and general health in a cross-sectional population-based sample of women. Scand J Public Health. 2018;46(5):580–7.CrossRefPubMed Lund I, Kvaavik E, Nygård M, Hansen BT. Associations between snus use, body mass index and general health in a cross-sectional population-based sample of women. Scand J Public Health. 2018;46(5):580–7.CrossRefPubMed
31.
go back to reference Lund I, Lund KE. Lifetime smoking habits among Norwegian men and women born between 1890 and 1994: a cohort analysis using cross-sectional data. BMJ Open. 2014;4:e005539.CrossRefPubMedPubMedCentral Lund I, Lund KE. Lifetime smoking habits among Norwegian men and women born between 1890 and 1994: a cohort analysis using cross-sectional data. BMJ Open. 2014;4:e005539.CrossRefPubMedPubMedCentral
32.
go back to reference Edvardsen HM, Moan IS, Christophersen AS, Gjerde H. Bruk av rusmidler, sløvende legemidler og tobakk blant arbeidstakere i utvalgte bransjer i Norge [Use of alcohol, drugs, psychoactive medication and tobacco among employees in a selection of industries in Norway], Report, Folkehelseinstituttet. Oslo: Norwegian Institute of Public Health; 2016. Edvardsen HM, Moan IS, Christophersen AS, Gjerde H. Bruk av rusmidler, sløvende legemidler og tobakk blant arbeidstakere i utvalgte bransjer i Norge [Use of alcohol, drugs, psychoactive medication and tobacco among employees in a selection of industries in Norway], Report, Folkehelseinstituttet. Oslo: Norwegian Institute of Public Health; 2016.
33.
go back to reference Johnson TP. Sources of error in substance use prevalence surveys. Int Sch Res Notices. 2014;923290. Johnson TP. Sources of error in substance use prevalence surveys. Int Sch Res Notices. 2014;923290.
Metadata
Title
The relative impact of smoking, alcohol use and drug use on general sickness absence among Norwegian employees
Authors
Ingeborg Lund
Inger Synnøve Moan
Hilde Marie Erøy Edvardsen
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2019
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-019-6891-1

Other articles of this Issue 1/2019

BMC Public Health 1/2019 Go to the issue